Associations of intimate partner violence with postnatal health practices in Bihar, India.

BMC Pregnancy Childbirth

Center on Gender Equity and Health, Department of Medicine, University of California, San Diego School of Medicine, San Diego, CA, USA.

Published: November 2017

Background: Reducing neonatal mortality is a global priority, and improvements in postnatal health (PNH) practices in India are needed to do so. Intimate partner violence (IPV) may be associated with PNH practices, but little research has assessed this relationship.

Methods: A cross-sectional analysis of data from a representative household sample of mothers of neonates 0-11 months old in Bihar, India was conducted. The relationship between lifetime IPV experience (physical violence only, sexual violence only, or both physical and sexual violence) and PNH practices [clean cord care, kangaroo mother care, early initiation of breastfeeding (EIBF), delayed bathing, receipt of a postnatal care visit, exclusive breastfeeding, and current post-partum contraceptive use] was assessed using multivariate logistic regression.

Results: Over 45% of the 10,469 mothers experienced IPV in their lifetime. The three types of IPV experiences differentially related to PNH practices. Adjusted analyses revealed that compared to those who had never experienced IPV, women who experienced physical violence only (29.0%) had higher odds of skin-to-skin care (AOR = 1.67, 95% CI = 1.42, 1.96) and delayed bathing (AOR = 1.19, 95% CI = 1.03, 1.37), but lower odds of EIBF (AOR = 0.81, 95% CI = 0.70, 0.93) and exclusive breastfeeding (AOR = 0.83, 95% CI = 0.71, 0.96). Mothers who had experienced sexual violence only (2.3%) had lower odds of practicing EIBF (AOR = 0.52, 95% CI = 0.36, 0.76). Those who had both experiences of physical and sexual violence (14.0%) had increased odds of postpartum modern contraceptive use (AOR = 1.35, 95% CI = 1.07, 1.71) and lower odds of delayed bathing (AOR = 0.76, 95% CI = 0.63, 0.91).

Conclusions: The results of this study found differing patterns of vulnerability to poor PNH practices depending on the type of IPV experienced. Efforts to increase access to health services for women experiencing IPV and to integrate IPV intervention into such service may increase PNH practices, and as a result, reduce neonatal mortality.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706152PMC
http://dx.doi.org/10.1186/s12884-017-1577-0DOI Listing

Publication Analysis

Top Keywords

pnh practices
24
sexual violence
16
delayed bathing
12
lower odds
12
intimate partner
8
violence
8
partner violence
8
postnatal health
8
bihar india
8
neonatal mortality
8

Similar Publications

More Than a Haematoma: A Case of Aplastic Anemia.

Cureus

December 2024

Family Medicine, Family Health Unit (USF) Almedina, Local Health Unit of Trás-os-Montes and Alto Douro (ULSTMAD), Lamego, PRT.

Easy bruising and ecchymosis are common symptoms in clinical practice, yet distinguishing benign from clinically significant cases can be challenging. We report the case of a 46-year-old woman who presented in December 2023 with easy bruising and increased menstrual flow, revealing new-onset pancytopenia in laboratory tests. Initially diagnosed with Acute Myeloid Leukemia inversion (inv) (16), subsequent results were inconclusive, leading to a diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH).

View Article and Find Full Text PDF

[Interpretation of the guidelines for diagnosing and treating paroxysmal nocturnal hemoglobinuria in China (2024)].

Zhonghua Xue Ye Xue Za Zhi

December 2024

Department of Hematology, General Hospital, Tianjin Medical University, Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin Institute of Hematology, Tianjin 300052, China.

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder of hematopoietic stem cells induced by PIG-A gene mutations. It is clinically manifested by hemolysis, bone marrow failure, and high-risk concurrent thrombosis, which are life-threatening in severe cases. Significant progress has been made in the pathogenesis research and clinical diagnosis and treatment of PNH in recent years.

View Article and Find Full Text PDF

Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.

Int J Mol Sci

November 2024

Cancer Center, Division of Hematology and Oncology, Department of Medicine, Taipei Municipal Wanfang Hospital, Taipei Medical University, No. 111, Section 3, Xinglong Rd, Wenshan District, Taipei City 11696, Taiwan.

Paroxysmal nocturnal hemoglobinuria (PNH) clones can be identified in a significant proportion of patients with aplastic anemia (AA). Screening for PNH clones at the time of an AA diagnosis is recommended by national and international guidelines. In this report, an expert panel of physicians discusses current best practices and provides recommendations for managing PNH in patients with AA in the Asia-Pacific region.

View Article and Find Full Text PDF
Article Synopsis
  • The 2022 update of Japanese guidelines for paroxysmal nocturnal hemoglobinuria (PNH) introduced improved diagnostic criteria and a new disease severity classification, enhancing clinical management.
  • It included 10 key clinical questions to guide treatment strategies and patient considerations, helping healthcare providers navigate PNH management more effectively.
  • New therapies, such as pegcetacoplan and danicopan, were approved to address PNH, with a focus not just on hemolysis but also on managing residual anemia and fatigue, influenced by real-world evidence.
View Article and Find Full Text PDF
Article Synopsis
  • Paroxysmal Nocturnal Haemoglobinuria (PNH) is a rare disorder that is difficult to diagnose due to diverse symptoms and a lack of awareness, often resulting in misdiagnosis.
  • This study explores the use of a machine learning model, specifically the XGBoost algorithm, to identify undiagnosed PNH patients using electronic health records from the UK, involving 131 PNH patients and over 593,000 controls.
  • The model achieved a recall rate of 27% for PNH patients, with a specificity of 99.99% for controls, and indicated that nearly 1 in 5 flagged patients may need further investigation for PNH, highlighting key symptoms like aplastic anemia and panc
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!